BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33975554)

  • 1. The role of surgical resection in primary central nervous system lymphoma: a single-center retrospective analysis of 70 patients.
    Wu S; Wang J; Liu W; Hu F; Zhao K; Jiang W; Lei T; Shu K
    BMC Neurol; 2021 May; 21(1):190. PubMed ID: 33975554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics, Surgical Outcomes, and Prognostic Factors of Intracranial Primary Central Nervous System Lymphoma.
    Ouyang T; Wang L; Zhang N; Zhang Z; Xiong Y; Li M; Hong T
    World Neurosurg; 2020 Jul; 139():e508-e516. PubMed ID: 32311566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of comorbidity indices and histochemical markers in surgically resected and non-resected primary central nervous system lymphoma.
    Wong CE; Liao WA; Chang Y; Lee PH; Huang CC; Chang KC; Lee JS
    Clin Exp Med; 2023 Nov; 23(7):3799-3807. PubMed ID: 37491648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whether surgical resection or biopsy makes difference in single lesion primary central nervous system lymphoma: a single center retrospective cohort study.
    Cheng X; Chen H; Sun C; Zhang B; Zhang J; Wang Y
    BMC Neurol; 2022 Nov; 22(1):411. PubMed ID: 36333683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary central nervous system lymphoma: Retrospective analysis of 34 cases in a single centre.
    Wang H; Wang M; Wei J; Wang L; Mao L; Jin J
    J Int Med Res; 2018 Feb; 46(2):883-894. PubMed ID: 28984175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemorrhagic Attitude in Frameless and Frame-Based Stereotactic Biopsy for Deep-Seated Primary Central Nervous System Lymphomas in Immunocompetent Patients: A Multicentric Analysis of the Last Twenty Years.
    Callovini GM; Sherkat S; Sperduti I; Crispo F; Raus L; Gazzeri R; Telera S
    World Neurosurg; 2021 May; 149():e1017-e1025. PubMed ID: 33476784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety of resection for primary central nervous system lymphoma: a single institution retrospective analysis.
    Cloney MB; Sonabend AM; Yun J; Yang J; Iwamoto F; Singh S; Bhagat G; Canoll P; Zanazzi G; Bruce JN; Sisti M; Sheth S; Connolly ES; McKhann G
    J Neurooncol; 2017 Mar; 132(1):189-197. PubMed ID: 28116650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resection or Biopsy: The Efficacy of Different Surgical Approaches for Primary Central Nervous System Lymphoma.
    Zhang Y; Wang Z; Wang D; Yu B; Wen J; He S; Zeng W; Wang C
    Turk Neurosurg; 2024; 34(3):401-406. PubMed ID: 38650554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma.
    Liu CJ; Lin SY; Yang CF; Yeh CM; Kuan AS; Wang HY; Tsai CK; Gau JP; Hsiao LT; Chen PM; Liu YC; Hong YC; Ko PS; Liu JH; Lin CH
    Cancer Med; 2020 Mar; 9(6):2134-2145. PubMed ID: 32011103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis, treatment, and outcome of primary CNS lymphoma-a single-center experience.
    Wismann J; Sommer-Sørensen RH; Kofoed MS; Halle B; Pedersen CB; Schulz MK; Grønhøj MH; Larsen TS; Møller MB; Poulsen FR
    Acta Neurochir (Wien); 2022 May; 164(5):1365-1373. PubMed ID: 35257217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Outcome and Overall Survival in Patients with Primary or Secondary CNS Lymphoma after Surgical Resection vs. Biopsy.
    Staub-Bartelt F; Rittenauer J; Sabel M; Rapp M
    Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of surgery in intracranial PCNSL.
    Jahr G; Da Broi M; Holte H; Beiske K; Meling TR
    Neurosurg Rev; 2018 Oct; 41(4):1037-1044. PubMed ID: 29383600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical resection versus biopsy in the treatment of primary central nervous system lymphoma: a systematic review and meta-analysis.
    Chojak R; Koźba-Gosztyła M; Polańska K; Rojek M; Chojko A; Bogacz R; Skorupa N; Więcław J; Czapiga B
    J Neurooncol; 2022 Dec; 160(3):753-761. PubMed ID: 36449256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis, prognosis and treatment of primary central nervous system lymphoma in the elderly population (Review).
    Liu Y; Yao Q; Zhang F
    Int J Oncol; 2021 Mar; 58(3):371-387. PubMed ID: 33650642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical Resection for Primary Central Nervous System Lymphoma: A Systematic Review.
    Labak CM; Holdhoff M; Bettegowda C; Gallia GL; Lim M; Weingart JD; Mukherjee D
    World Neurosurg; 2019 Jun; 126():e1436-e1448. PubMed ID: 30904794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database].
    Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytoreductive Surgery for Primary Central Nervous System Lymphoma: Is it time to consider extent of resection?
    Singhal S; Antoniou E; Kwan E; Gregory G; Lai LT
    J Clin Neurosci; 2022 Dec; 106():110-116. PubMed ID: 36274297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary central nervous system lymphoma involving the hypothalamic-pituitary axis: a case series and pooled analysis.
    Shin DW; Kim JH; Kim YH; Cho YH; Hong SH
    J Neurooncol; 2020 Apr; 147(2):339-349. PubMed ID: 32221784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study.
    Li J; Tang X; Luo X; Liu L; Li D; Yang L
    Ann Hematol; 2023 Aug; 102(8):2153-2163. PubMed ID: 37289220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMSE is an independent prognostic factor for survival in primary central nervous system lymphoma.
    van der Meulen M; Dirven L; Bakunina K; van den Bent MJ; Issa S; Doorduijn JK; Bromberg JEC
    J Neurooncol; 2021 Apr; 152(2):357-362. PubMed ID: 33611761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.